Adriana Hernandez
About Adriana Hernandez
Adriana Hernandez is a Cell Therapy Specialist III Lead at Kite Pharma, where she has worked since 2021. She has a background in quality assurance and has held various roles in education and technology support.
Current Role at Kite Pharma
Adriana Hernandez serves as the Cell Therapy Specialist III Lead at Kite Pharma, a position she has held since 2021. In this role, she is responsible for overseeing various aspects of cell therapy processes and ensuring compliance with industry standards. Her work is based in El Segundo, California, where she contributes to the advancement of innovative treatments in the field of cell therapy.
Previous Experience in Quality Assurance
Prior to her current role, Adriana Hernandez worked as a Quality Assurance Laboratory Technician at Cacique, Inc. for seven months in 2017. She also held a position as a QA Lab Technician at Aerotek for five months in 2016. These roles provided her with essential experience in quality assurance protocols and laboratory practices.
Experience in Education and Student Support
Adriana Hernandez has a background in educational support, having worked at El Camino College in various capacities. She served as a Student Enhancement Team Consultant from 2013 to 2016 and as a MESA Staff member from 2010 to 2012. Additionally, she worked as a Department of Industry and Technology Student Worker from 2009 to 2010, contributing to student development and academic success.
Educational Background in Microbiology
Adriana Hernandez earned her Bachelor of Science degree in Microbiology from California State University-Long Beach, where she studied from 2012 to 2016. This academic foundation has equipped her with the knowledge and skills necessary for her roles in cell therapy and quality assurance.
Career Progression at Kite Pharma
Adriana Hernandez's career at Kite Pharma began as a Cell Therapy Specialist I, a position she held from 2017 to 2020. She advanced to the role of Cell Therapy Specialist II before her current position as Cell Therapy Specialist III Lead. This progression reflects her growing expertise and contributions to the field of cell therapy.